A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer

Conditions: Breast Cancer Interventions: Drug: Trastuzumab+pyrotinib+taxene Sponsors: Huihua Xiong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials